Research and Clinical Trials

Title  

Seattle Children's Hospital / PBMTC GVH 1201: Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial

Brief Description  

To determine the impact that abatacept will make on the incidence of early, severe acute GVHD (aGvHD), when it is added to a standard GvHD prophylaxis regimen during unrelated-donor hematopoietic stem cell transplantation (HSCT) for patients with hematologic malignancies.

Who may be Eligible  

Please contact us for eligibility criteria.

Speciality/Disorder  

Other Hematopoietic

Status  

OPEN

Start Date  

03/19/2017

IRB Number  

00017275

Principal Investigator  

Huo, Jeffrey

Contact Name  

Tracy L Fukes

For More Information, Contact  Tracy  L, Fukes
Phone:  980-442-2310 Fax:    
Email:  tracy.fukes@atriumhealth.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204